Cytochrome P450 2C19 polymorphism and clopidogrel after MI

被引：2
|
作者：
Ramaraj, Radhakrishnan [1 ]
机构：
[1] Univ Arizona, Coll Med, Dept Internal Med, Tucson, AZ 85724 USA
来源：
LANCET | 2009年 / 373卷 / 9670期
关键词：
TRIAL;
D O I：
10.1016/S0140-6736(09)60681-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1172 / 1172
页数：1
相关论文
共 42 条
  • [1] Cytochrome P450 2C19 Polymorphism and Antiplatelet Therapy. Who Should Really be Genotyped?
    Kassimis, George
    Stavrou, Eleana F.
    Alexopoulos, Dimitrios
    Athanassiadou, Aglaia
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (13) : 2489 - 2495
  • [2] Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents
    Oh, Il-Young
    Park, Kyung Woo
    Kang, Si-Hyuk
    Park, Jin Joo
    Na, Sang-Hoon
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Jeong, Young-Hoon
    Hwang, Jin-Yong
    Kwak, Choong Hwan
    Park, Yongwhi
    Hwang, Seok-Jae
    Ko, Young-Guk
    Shin, Dong Jik
    Jang, Yangsoo
    Kim, Hyo-Soo
    HEART, 2012, 98 (02) : 139 - 144
  • [3] Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel
    Reese, Emily S.
    Mullins, C. Daniel
    Beitelshees, Amber L.
    Onukwugha, Eberechukwu
    PHARMACOTHERAPY, 2012, 32 (04): : 323 - 332
  • [4] Cytochrome P450 2C19 Polymorphism, Suboptimal Reperfusion and All-Cause Mortality in Patients with Acute Myocardial Infarction
    Malek, Lukasz A.
    Przyluski, Jakub
    Spiewak, Mateusz
    Klopotowski, Mariusz
    Kostrzewa, Grazyna
    Kruk, Mariusz
    Ploski, Rafal
    Witkowski, Adam
    Ruzyllo, Witold
    CARDIOLOGY, 2010, 117 (02) : 81 - 87
  • [5] Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleeding
    Sorich, Michael J.
    Polasek, Thomas M.
    Wiese, Michael D.
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (01) : 199 - 200
  • [6] Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel in Patients With Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype
    Kim, In-Suk
    Jeong, Young-Hoon
    Park, Yongwhi
    Park, Ki-Soo
    Yun, Seong-Eun
    Park, Jeong-Rang
    Hwang, Seok-Jae
    Koh, Eun-Ha
    Kwak, Choong Hwan
    Hwang, Jin-Yong
    Kim, Sunjoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) : 381 - 391
  • [7] Impact of Cytochrome P450 2C9 Polymorphism on Warfarin Therapy in Saudi Population
    Al-Saikhan, Fahad Ibrahim
    Abd-Elaziz, Mohamed Abd-Elghany
    Ashour, Rehab Hamdy
    Langaee, Taimour
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (04) : 566 - 571
  • [8] Evaluation of Liposomal Curcumin Cytochrome P450 Metabolism
    Mach, Claire M.
    Chen, Jing Hong
    Mosley, Scott A.
    Kurzrock, Razelle
    Smith, Judith A.
    ANTICANCER RESEARCH, 2010, 30 (03) : 811 - 814
  • [9] Epoxidation of perillyl alcohol by engineered bacterial cytochrome P450 BM3
    Park, Chan Mi
    Cha, Gun Su
    Jeong, Hae Chan
    Lee, Yu-jin
    Kim, Jeong-Hoon
    Chung, Moon-Soo
    Lee, Sungbeom
    Yun, Chul-Ho
    ENZYME AND MICROBIAL TECHNOLOGY, 2024, 180
  • [10] Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol
    Qu, Yan-Qing
    Fang, Zhong-Ze
    Yang, Ling
    Gao, Zhen-Ming
    Liang, Rui
    Zhu, Liang-Liang
    Dong, Pei-Pei
    Zhang, Yan-Yan
    Ge, Guang-Bo
    Wang, Li-Ming
    PHARMAZIE, 2011, 66 (03): : 216 - 221
12345